A cohort study of the target protein as a novel tumor marker for patients with ovarian clear cell carcinoma befor or after surgery.

A cohort study of the target protein as a novel tumor marker for patients with ovarian clear cell carcinoma befor or after surgery. - A cohort study of a novel ovarian CCC tumor marker

Status

Recruiting

Phases

Unknown

Study type

Observational

Source

JPRN

Registry ID

JPRN-UMIN000027404

Enrollment

Registered

2017-07-01

Start date

2017-09-15

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Ovarian clear cell carcinoma

Interventions

None listed

Eligibility

Sex/Gender

Female

Inclusion criteria

Inclusion criteria: 1. Patinets whose pre-treatment serum samples are obetained. 2.Patients who submitted the documment for written informed consent

Exclusion criteria

Exclusion criteria: 1. Patients who are judged as being inappropriate for this study. 2. Patients during pregnancy

Design outcomes

Primary

Measure	Time frame
Changes in serum levels of target protein and CA125 before and after surgery(every 1-3 month)	—

Countries

Japan

Contacts

Public ContactYusuke Kunimi

Kochi Health Science Center Gynecology

yuusuke_kunimi@khsc.or.jp088-837-3000

Outcome results